University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Jonathan Singer, M.D.

Pulmonologist

Dr. Jonathan Singer is a pulmonologist and critical care specialist in the Lung Transplant Program who treats patients with advanced lung disease, before and after lung transplants. He treats conditions such as idiopathic pulmonary fibrosis, interstitial lung disease (ILD), connective-tissue disease associated with ILD, hypersensitivity pneumonitis, cystic fibrosis and chronic obstructive pulmonary disease.

In his research, he studies outcomes in lung transplantation and how lung transplants improve function, reduces disability and improves health-related quality of life. A second area of research is employing advanced statistical modeling techniques to identify pre-transplant risk factors associated with important outcomes following lung transplantation. Singer earned a medical degree and master's of science degree in the joint UC Berkeley and UCSF program. He completed a residency at UCSF in internal medicine and fellowships in pulmonary and critical care medicine and lung and heart-lung transplantation, both at UCSF. He is a member of the American Thoracic Society, International Society for Heart and Lung transplantation, American College of Chest Physicians and European Respiratory Society. Singer is board certified in internal medicine, pulmonary medicine and critical care medicine. He is a clinical instructor of medicine at UCSF.

Clinics

Lung Transplant Program
400 Parnassus Ave., Sixth Floor
San Francisco, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday 8 a.m. – 5 p.m. (exact times vary depending on number of physicians in clinic)

Conditions & Treatments

More about Jonathan Singer

Education

UCSF Medical Center School of Medicine 2004

Residencies

UC San Francisco Medical Center 2007

Fellowships

UC San Francisco Medical Center 2010

Selected Research and Publications

  1. Singer JP, Singer LG. Quality of life in lung transplantation. Semin Respir Crit Care Med. 2013 Jun; 34(3):421-30.
  2. Sottile PD, Iturbe D, Katsumoto TR, Connolly MK, Collard HR, Leard LA, Hays S, Golden JA, Hoopes C, Kukreja J, Singer JP. Outcomes in systemic sclerosis-related lung disease after lung transplantation. Transplantation. 2013 Apr 15; 95(7):975-80.
  3. Singer JP, Chen J, Blanc PD, Leard LE, Kukreja J, Chen H. A thematic analysis of quality of life in lung transplant: the existing evidence and implications for future directions. Am J Transplant. 2013 Apr; 13(4):839-50.
  4. Sayah DM, Schwartz BS, Kukreja J, Singer JP, Golden JA, Leard LE. Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis. Transpl Infect Dis. 2013 Apr; 15(2):E70-4.
  5. Sayah DM, Koff JL, Leard LE, Hays SR, Golden JA, Singer JP. Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection. Clin Transplant. 2013 Jan-Feb; 27(1):E64-71.
  6. Singer JP, Yusen RD. Defining patient-reported outcomes in chronic obstructive pulmonary disease: the patient-centered experience. Med Clin North Am. 2012 Jul; 96(4):767-87.
  7. Singer JP, Katz PP, Iribarren C, Omachi TA, Sanchez G, Yelin EH, Cisternas MG, Blanc PD. Both pulmonary and extra-pulmonary factors predict the development of disability in chronic obstructive pulmonary disease. Respiration. 2013; 85(5):375-83.
  8. Okamoto T, Miyazaki Y, Tomita M, Tamaoka M, Inase N. A familial history of pulmonary fibrosis in patients with chronic hypersensitivity pneumonitis. Respiration. 2013; 85(5):384-90.
  9. Zutler M, Singer JP, Omachi TA, Eisner M, Iribarren C, Katz P, Blanc PD. Relationship of obesity with respiratory symptoms and decreased functional capacity in adults without established COPD. Prim Care Respir J. 2012 Jun; 21(2):194-201.
  10. Singer JP, Boker A, Metchnikoff C, Binstock M, Boettger R, Golden JA, Glidden DV, Arron ST. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients. J Heart Lung Transplant. 2012 Jul; 31(7):694-9.
  11. Wiita AP, Roubinian N, Khan Y, Chin-Hong PV, Singer JP, Golden JA, Miller S. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis. Transpl Infect Dis. 2012 Jun; 14(3):248-58.
  12. Metchnikoff C, Mully T, Singer JP, Golden JA, Arron ST. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients. J Am Acad Dermatol. 2012 Nov; 67(5):829-35.
  13. Watkins KD, Boettger RF, Hanger KM, Leard LE, Golden JA, Hoopes CW, Singer JP. Use of sublingual tacrolimus in lung transplant recipients. J Heart Lung Transplant. 2012 Feb; 31(2):127-32.
  14. Smith L, Singer JP, Hayes M, Golden JA, Leard LE. An analysis of potential risk factors for early complications from fiberoptic bronchoscopy in lung transplant recipients. Transpl Int. 2012 Feb; 25(2):172-8.
  15. Singer JP, Chen H, Phelan T, Kukreja J, Golden JA, Blanc PD. Survival following lung transplantation for silicosis and other occupational lung diseases. Occup Med (Lond). 2012 Mar; 62(2):134-7.
  16. Singer JP, Blanc PD, Hoopes C, Golden JA, Koff JL, Leard LE, Cheng S, Chen H. The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation. Am J Transplant. 2011 Oct; 11(10):2197-204.
  17. Singer J, Yelin EH, Katz PP, Sanchez G, Iribarren C, Eisner MD, Blanc PD. Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function. J Cardiopulm Rehabil Prev. 2011 Mar-Apr; 31(2):111-9.
  18. Ibrahim SF, Singer JP, Arron ST. Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole. Dermatol Surg. 2010 Nov; 36(11):1752-5.
  19. Singer JP, Kohlwes J, Bent S, Zimmerman L, Eisner MD. The impact of a "low-intensity" versus "high-intensity" medical intensive care unit on patient outcomes in critically ill veterans. J Intensive Care Med. 2010 Jul; 25(4):233-9.
  20. Singer JP, Huang MY, Hui C, Blanc PD, Boettger RF, Golden J, Watkins K, Hoopes C, Leard LE. Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients. J Heart Lung Transplant. 2010 Sep; 29(9):1009-13.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.